Assignee
ITERION THERAPEUTICS INC
US·10 granted patents·5 pending applications·6 citations·filing 2019–2025
Top patents by PatentIndex Score
15 records- 0188US11602501B2Lyophilized formulations of tegavivintITERION THERAPEUTICS INC·Filed 2021·Granted Mar 14, 2023·1 cites·22 claims
- 0288US11136307B1Crystalline form of tegavivint, method of preparation, and use thereofITERION THERAPEUTICS INC·Filed 2020·Granted Oct 5, 2021·2 cites·15 claims
- 0384US12491162B2Formulations of tegavivintITERION THERAPEUTICS INC·Filed 2024·Granted Dec 9, 2025·0 cites·17 claims
- 0484US12208166B2Lyophilized formulations of tegavivintITERION THERAPEUTICS INC·Filed 2023·Granted Jan 28, 2025·0 cites·26 claims
- 0583US2026096992A1Formulations of tegavivintITERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0679US11266637B2Formulations of tegavivint and related compoundsITERION THERAPEUTICS INC·Filed 2019·Granted Mar 8, 2022·3 cites·11 claims
- 0778US11964054B2Formulations of tegavivintITERION THERAPEUTICS INC·Filed 2023·Granted Apr 23, 2024·0 cites·16 claims
- 0878US2025263391A1Crystalline form of tegavivint, method of preparation, and use thereofITERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0974US11793759B2Lyophilized formulations of tegavivintITERION THERAPEUTICS INC·Filed 2021·Granted Oct 24, 2023·0 cites·27 claims
- 1072US11571388B2Lyophilized formulations of tegavivintITERION THERAPEUTICS INC·Filed 2020·Granted Feb 7, 2023·0 cites·21 claims
- 1171US12297185B2Crystalline form of tegavivint, method of preparation, and use thereofITERION THERAPEUTICS INC·Filed 2021·Granted May 13, 2025·0 cites·20 claims
- 1271US12246010B2Formulations of tegavivint and related compoundsITERION THERAPEUTICS INC·Filed 2022·Granted Mar 11, 2025·0 cites·15 claims
- 1371US2025152515A1Lyophilized formulations of tegavivintITERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1466US2025205212A1Formulations of tegavivint and related compoundsITERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1559US2023012615A1Methods for treatment of fibrotic diseasesITERION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ITERION THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →